Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study (vol 14, 1109771, 2023)
FRONTIERS IN IMMUNOLOGY（2023）
关键词
unresectable hepatocellular carcinoma, TACE, levantinib, anti-PD-1 antibody, immunotherapy, nomogram
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要